FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366991859> ?p ?o ?g. }

• W4366991859 endingPage "2258" @default.
• W4366991859 startingPage "2243" @default.
• W4366991859 abstract "Real-world data on the EGFR mutational profile upon progression after first/second-generation EGFR-TKI treatment in patients with advanced non-small-cell lung cancer (NSCLC) and treatment strategies employed thereon are needed.This observational study was conducted in 23 hospital-based lung cancer Centers in Greece (protocol code: D133FR00126). Ninety-six eligible patients were consecutively enrolled between July-2017 and September-2019. Re-biopsy was performed in 18 of 79 patients who tested T790M-negative in liquid biopsy after progression in the first-line (1L) setting.Of the study population, 21.9% tested T790M-positive, while 72.9% proceeded to 2L treatment, mainly comprising of a third-generation EGFR-TKI (48.6%), a switch to chemotherapy (30.0%), or chemo-immunotherapy (17.1%). The objective response rate (ORR) in 2L was 27.9% in T790M-negative and 50.0% in T790M-positive patients. Of evaluable patients, 67.2% experienced disease progression; median progression-free survival (PFS) was 5.7 and 10.0 months among T790M-negative and positive patients, respectively. Among T790M-negative patients, longer median PFS and post-progression survival were observed with third-generation EGFR-TKI treatment.Mutational status and treatment strategy were identified as critical determinants of clinical outcomes in the 2L-setting of EGFR-mutated NSCLC patients in real-world settings in Greece, with early diagnosis, appropriate molecular testing and high-efficacy treatments at first lines positively affecting ORR and PFS." @default.
• W4366991859 created "2023-04-27" @default.
• W4366991859 creator A5000796708 @default.
• W4366991859 creator A5001104817 @default.
• W4366991859 creator A5001684767 @default.
• W4366991859 creator A5001926067 @default.
• W4366991859 creator A5006337734 @default.
• W4366991859 creator A5009163670 @default.
• W4366991859 creator A5011764519 @default.
• W4366991859 creator A5013973547 @default.
• W4366991859 creator A5015401016 @default.
• W4366991859 creator A5015437737 @default.
• W4366991859 creator A5015800207 @default.
• W4366991859 creator A5017873896 @default.
• W4366991859 creator A5020731228 @default.
• W4366991859 creator A5021778173 @default.
• W4366991859 creator A5027224419 @default.
• W4366991859 creator A5027241872 @default.
• W4366991859 creator A5033733633 @default.
• W4366991859 creator A5038360754 @default.
• W4366991859 creator A5044610238 @default.
• W4366991859 creator A5051459889 @default.
• W4366991859 creator A5057590983 @default.
• W4366991859 creator A5068202398 @default.
• W4366991859 creator A5073391140 @default.
• W4366991859 creator A5074319658 @default.
• W4366991859 creator A5084377238 @default.
• W4366991859 creator A5084550691 @default.
• W4366991859 creator A5090781866 @default.
• W4366991859 date "2023-04-25" @default.
• W4366991859 modified "2023-09-26" @default.
• W4366991859 title "Clinical Outcomes Beyond 1L<i>EGFR</i>-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’" @default.
• W4366991859 doi "https://doi.org/10.21873/anticanres.16388" @default.
• W4366991859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37097667" @default.
• W4366991859 hasPublicationYear "2023" @default.
• W4366991859 type Work @default.
• W4366991859 citedByCount "0" @default.
• W4366991859 crossrefType "journal-article" @default.
• W4366991859 hasAuthorship W4366991859A5000796708 @default.
• W4366991859 hasAuthorship W4366991859A5001104817 @default.
• W4366991859 hasAuthorship W4366991859A5001684767 @default.
• W4366991859 hasAuthorship W4366991859A5001926067 @default.
• W4366991859 hasAuthorship W4366991859A5006337734 @default.
• W4366991859 hasAuthorship W4366991859A5009163670 @default.
• W4366991859 hasAuthorship W4366991859A5011764519 @default.
• W4366991859 hasAuthorship W4366991859A5013973547 @default.
• W4366991859 hasAuthorship W4366991859A5015401016 @default.
• W4366991859 hasAuthorship W4366991859A5015437737 @default.
• W4366991859 hasAuthorship W4366991859A5015800207 @default.
• W4366991859 hasAuthorship W4366991859A5017873896 @default.
• W4366991859 hasAuthorship W4366991859A5020731228 @default.
• W4366991859 hasAuthorship W4366991859A5021778173 @default.
• W4366991859 hasAuthorship W4366991859A5027224419 @default.
• W4366991859 hasAuthorship W4366991859A5027241872 @default.
• W4366991859 hasAuthorship W4366991859A5033733633 @default.
• W4366991859 hasAuthorship W4366991859A5038360754 @default.
• W4366991859 hasAuthorship W4366991859A5044610238 @default.
• W4366991859 hasAuthorship W4366991859A5051459889 @default.
• W4366991859 hasAuthorship W4366991859A5057590983 @default.
• W4366991859 hasAuthorship W4366991859A5068202398 @default.
• W4366991859 hasAuthorship W4366991859A5073391140 @default.
• W4366991859 hasAuthorship W4366991859A5074319658 @default.
• W4366991859 hasAuthorship W4366991859A5084377238 @default.
• W4366991859 hasAuthorship W4366991859A5084550691 @default.
• W4366991859 hasAuthorship W4366991859A5090781866 @default.
• W4366991859 hasConcept C121608353 @default.
• W4366991859 hasConcept C126322002 @default.
• W4366991859 hasConcept C143998085 @default.
• W4366991859 hasConcept C2776256026 @default.
• W4366991859 hasConcept C2776694085 @default.
• W4366991859 hasConcept C2777930144 @default.
• W4366991859 hasConcept C2779256057 @default.
• W4366991859 hasConcept C2779438470 @default.
• W4366991859 hasConcept C2780580887 @default.
• W4366991859 hasConcept C2780739268 @default.
• W4366991859 hasConcept C2908647359 @default.
• W4366991859 hasConcept C71924100 @default.
• W4366991859 hasConcept C99454951 @default.
• W4366991859 hasConceptScore W4366991859C121608353 @default.
• W4366991859 hasConceptScore W4366991859C126322002 @default.
• W4366991859 hasConceptScore W4366991859C143998085 @default.
• W4366991859 hasConceptScore W4366991859C2776256026 @default.
• W4366991859 hasConceptScore W4366991859C2776694085 @default.
• W4366991859 hasConceptScore W4366991859C2777930144 @default.
• W4366991859 hasConceptScore W4366991859C2779256057 @default.
• W4366991859 hasConceptScore W4366991859C2779438470 @default.
• W4366991859 hasConceptScore W4366991859C2780580887 @default.
• W4366991859 hasConceptScore W4366991859C2780739268 @default.
• W4366991859 hasConceptScore W4366991859C2908647359 @default.
• W4366991859 hasConceptScore W4366991859C71924100 @default.
• W4366991859 hasConceptScore W4366991859C99454951 @default.
• W4366991859 hasIssue "5" @default.
• W4366991859 hasLocation W43669918591 @default.
• W4366991859 hasLocation W43669918592 @default.
• W4366991859 hasOpenAccess W4366991859 @default.
• W4366991859 hasPrimaryLocation W43669918591 @default.
• W4366991859 hasRelatedWork W2026342389 @default.
• W4366991859 hasRelatedWork W2055244776 @default.

• next